Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.
作者信息
Mukhopadhyay S, Singh M, Ogston S, Ryan G, Smyth R
机构信息
University of Dundee Department of Child Health, Ninewells Hospital and Medical School, Scotland, UK.
出版信息
J R Soc Med. 1998;91 Suppl 34(Suppl 34):25-9. doi: 10.1177/014107689809134S05.
Abstract
摘要
相似文献
1
Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.囊性纤维化雾化抗生素的系统评价：方案的演变
J R Soc Med. 1998;91 Suppl 34(Suppl 34):25-9. doi: 10.1177/014107689809134S05.
2
Evidence for using nebulised antibiotics in cystic fibrosis.雾化吸入抗生素用于囊性纤维化的证据。
Arch Dis Child. 1999 Apr;80(4):307-9. doi: 10.1136/adc.80.4.307.
3
Pseudomonas eradication in cystic fibrosis: who will join the ELITE?
Thorax. 2010 Apr;65(4):281-2. doi: 10.1136/thx.2009.130708.
4
Mechanism of action of antibiotics in chronic pulmonary pseudomonas infection.
Adv Pharmacol. 1994;30:53-84. doi: 10.1016/s1054-3589(08)60172-6.
5
Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.囊性纤维化的抗菌治疗。对1980年至1987年2月发表的文献综述。
Chest. 1988 Aug;94(2 Suppl):129S-140S. doi: 10.1378/chest.94.2.129s.
6
Cystic fibrosis and the pseudomonads.囊性纤维化与假单胞菌属
Br J Biomed Sci. 1996 Jun;53(2):140-5.
7
Pseudomonas infection in CF (cystic fibrosis).囊性纤维化（CF）中的铜绿假单胞菌感染。
Thorax. 2000 Dec;55(12):1070-1. doi: 10.1136/thorax.55.12.1070b.
8
Should pulmonary exacerbations in cystic fibrosis be treated with antibiotics?囊性纤维化患者的肺部加重期应使用抗生素治疗吗？
Drug Intell Clin Pharm. 1984 Oct;18(10):825-6. doi: 10.1177/106002808401801018.
9
[Making antibiotic therapy easier to use. A welcome advance for those with cystic fibrosis].[使抗生素治疗更易于使用。对囊性纤维化患者来说是一项值得欢迎的进展]
Perspect Infirm. 2011 Jul-Aug;8(4):54-5.
本文引用的文献
1
The Cochrane Collaboration: the role of the UK Cochrane Centre in identifying the evidence.
Health Libr Rev. 1994 Dec;11(4):235-42. doi: 10.1046/j.1365-2532.1994.1140235.x.
2
Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.囊性纤维化患者雾化抗假单胞菌抗生素治疗：效益与风险的荟萃分析
Thorax. 1996 Apr;51(4):364-8. doi: 10.1136/thx.51.4.364.
3
The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis.
Respir Med. 1994 Mar;88(3):203-11. doi: 10.1016/s0954-6111(05)80348-8.
4
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.偏倚的实证证据。与对照试验中治疗效果估计相关的方法学质量维度。
JAMA. 1995 Feb 1;273(5):408-12. doi: 10.1001/jama.273.5.408.
5
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.雾化重组人脱氧核糖核酸酶对囊性纤维化患者呼吸道症状加重及肺功能的影响。Pulmozyme研究组。
N Engl J Med. 1994 Sep 8;331(10):637-42. doi: 10.1056/NEJM199409083311003.
6
Pseudomonas infection, allergy, and cystic fibrosis.假单胞菌感染、过敏和囊性纤维化。
Arch Dis Child. 1982 Aug;57(8):582-6. doi: 10.1136/adc.57.8.582.
7
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.雾化羧苄青霉素和庆大霉素治疗囊性纤维化患者的铜绿假单胞菌感染
Lancet. 1981 Nov 21;2(8256):1137-9. doi: 10.1016/s0140-6736(81)90588-2.
8
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.氨基糖苷类药物在囊性纤维化痰液中的渗透、失活及疗效。
Am Rev Respir Dis. 1985 Oct;132(4):761-5. doi: 10.1164/arrd.1985.132.4.761.
9
Quantitative deposition of aerosolized gentamicin in cystic fibrosis.雾化庆大霉素在囊性纤维化中的定量沉积
Am Rev Respir Dis. 1987 Dec;136(6):1445-9. doi: 10.1164/ajrccm/136.6.1445.
10
Cystic fibrosis in adolescents and adults.青少年及成人的囊性纤维化
Ir Med J. 1991;84(4):121-4.
Zotero 插件